Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I don't see how they can keep the SS the same. Someone mentioned they have no debt, but they have no revenues either. Unless COIN is willing to take future revenues as payment down the road, Lotus will have to give them a big chunk of stock. This just seems like a strange marriage. IMO, this is a very short-term play due to the chance dilution can end up hurting the price down the road.
Yes you are! I hope you got in as cheap as I did and have plenty of shares for the ride up.
Yep. Glad to see you sticking around. You usually don't sit on anything very long KUMO.
This thing just needs volume to run. Hitting the Ask for 100 shares bleeds off price over time! Hopefully we will have a good Jan!
Looks like we have our first Troll popping up to try and get your shares cheap. Always happens when you see a big move.
I agree with you KUMO on the contracts. Just thinking it will take quite a few of them to get to a point of buying other companies. Hopefully they will keep winning them!
Where are they getting the money to do the aquiring? My hope is they don't blow up this nice stock structure to do so. With decent news not moving the needle at all (today) my fear is dilution may be their answer for buying these other companies. Just my thoughts here...
These guys need to hire a PR firm. May be one of the biggest hidden gems around that nobody knows about.
Also, who in the heck is market making for them? The spread today was so far out of whack I don't even know what to say about it.
Not a big fan of somewhat big (comparable to volume) T trades happening the last three days at super low prices.
I'm accumulating. Most of the buying action was me today in two trades.
60% spread is ridiculous.
I hit the Ask today. Not sure why this isn't going higher.
Oh, I'm not selling. Definitely not buying more though after that rotten sandwich we were just delivered.
Ugly Quarterly Report out.
https://www.otcmarkets.com/stock/IMTL/filings
Man, you were right on the money. Let's hope this is the bottom.
So you missed this news release on the 19th?
LOS ANGELES, CA -- (Marketwired) -- 10/19/17 -- ViaDerma, Inc.(VDRM), a specialty pharmaceutical company devoted to bringing new products to market, recently announced today that the Company has begun distribution of its highly anticipated topical antibiotic ointment. Its marketing, sales and distribution partner, Biogenx, Inc. has been preselling the product, under the name of VitaStem™, which retails for $99 and can be purchased online at www.Biogenx.net. The Company's manufacturing partner has completed the first production run of 15,000 units of the product overcoming several manufacturing delays. The Company expects to ramp up production on a monthly basis and the first orders shipped out yesterday. Since the promising results of clinical studies of VitaStem in hospital groups in Japan and the Philippines, the Company will send a portion of the first run to Japan and the Philippines. The Distributors are also interested in ViaDerma's(VDRM) several follow-on products, using ViaDerma's(VDRM) proprietary solution, which the Company is expecting additional FDA registration numbers throughout the rest of 2017.
The Company's President, Dr. Christopher Otiko said, "Now that the product delays are over and we are in the distribution phase we expect the orders to come in from several key countries abroad. The quick response by customers in our marketing studies has shown positive results and this has led to an increased interest in our products due to the need in several markets around the world. This should open the door for future products in several key markets. Our contract manufacturer has the capabilities to manufacture most of our products and we look forward to building a lasting relationship to deliver high quality pharmaceuticals to our distributors."
About ViaDerma, Inc.(VDRM)
ViaDerma, Inc. (VDRM) is a publicly traded specialty pharmaceutical company committed to bringing new products to market and licensing its innovative technology to current leaders in the pharmaceutical industry in a wide variety of therapeutic areas. ViaDerma's(VDRM) products use an innovative transdermal delivery method that allows for application of active ingredients in a topical form. This patent-pending dual carrier transdermal technology may be applied in products within the medical and cosmetic markets. Also, a patent application using the combination of CBD's and THC with the delivery system was filed in 2017. The use of CBD's is for the reduction of inflammation and for the treatment of several diseases, such as, nicotine addiction, fibromyalgia, Crohn's disease, schizophrenia, migraine headaches, pain management for cancer and Multiple Sclerosis. For more information, please visit: www.viadermalicensing.com
Forward Looking Statements
Forward-Looking Statements certain statements in this release that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be identified using words such as "anticipate," "believe," "expect," "future," "may," "will," "would," "should," "plan," "projected," "intend," and similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements. The Company's future operating results are dependent upon many factors, including but not limited to the Company's ability to: (i) obtain sufficient capital or a strategic business arrangement to fund its expansion plans; (ii) build the management and human resources and infrastructure necessary to support the growth of its business; (iii) competitive factors and developments beyond the Company's control; and (iv) other risk factors. We assume no obligation to update the information contained in this news release.
Contact information:
Investor Relations
Email: info@viadermalicensing.com
Phone: 310- 734-6111
Source: ViaDerma, Inc.(VDRM)
Dang, that stinks!!!!
What platform? I was able to get my shares a few weeks ago on Fidelity.
Would help for sure. Wouldn't take much to move the needle in the right direction. Concerned because they said news would be imminent, yet it has been over a month.
Not good when there are people out here with large positions who can't even unwind them a little if they want due to the low volume. More concerning is NOBODY wants to even spend $165 to slap the Ask at these levels.
Can't do much with low volume days like this:
Date Volume
10/18/2017 4,000
10/17/2017 00
10/16/2017 15,890
10/13/2017 158,800
10/12/2017 10,000
10/11/2017 14,000
About 95% of these are sells, but the volume is so low it really doesn't look like a lot of dumping.
This helps us how?
Not sure why someone would wait until it is under 2 cents to short it. At .10 that would have made sense, but not down here. I think people are just selling because no updates and no volume indicate nothing is happening here short term, just IMO of course.
Level 2 is showing all sells. Sorry. :(
Took a 155K position in this late yesterday. Chart looked pretty good, but the trading was confusing today. Does anyone expect news to follow their Sept announcement that they are re-entering the CBD market with products? Thanks.
T trades back the last two sessions. Guess the dilution is ongoing...
No, he's still there. It was the CFO who resigned at the end of August.
It is ridiculous. Had a few big ones last week, too.
Stats do not matter on this one. There are trades happening below the bid constantly the last 3 days. It will get to .011 today I think. Hate to see it since I got in at .0420.
Agreed. It just seems the last two sessions have seen accelerated drops.
How so? It looks like some big buyers getting in early in the day and then selling late.
Has anyone here been in direct contact with the company? The drop here over the last week is alarming!
I think the biggest problem here is total lack of interest in the overall deal. For PMEA, the Bid stacking and Ask slowly coming down over the last week IMO is indicative of a tepid response for the SEIL deal. This could very easily walk all the way down to .0001 this week. However, Goldpenny and others bring up several great points of how a deal like this is SUPPOSED to work.
I'm more concerned about SEIL. More often than not, a company like this that is so thinly traded and really doesn't have any "products" to offer sets up a diabolical drop in the PPS once all the new shares hit the market. I've seen it time and time again. Day one there could be a real possibility SEIL is trading just like PMEA is now, in the .0004 to .0005 range and we've all lost both ways and the Brothers Bourne walk off into the sunset with our money and then resurface months later with new shells offering new ideas.
I'm hopeful this is not the case as I have a modest position in PMEA and have tried to catch the falling knife over the last three months from .0018 on down. This is my first post, but have been following this board and riding on all the highs and lows with you all.